<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref86">
 <mixed-citation publication-type="journal" id="cit86">
  <name>
   <surname>Pyrc</surname>
   <given-names>K.</given-names>
  </name>; 
  <name>
   <surname>Bosch</surname>
   <given-names>B. J.</given-names>
  </name>; 
  <name>
   <surname>Berkhout</surname>
   <given-names>B.</given-names>
  </name>; 
  <name>
   <surname>Jebbink</surname>
   <given-names>M. F.</given-names>
  </name>; 
  <name>
   <surname>Dijkman</surname>
   <given-names>R.</given-names>
  </name>; 
  <name>
   <surname>Rottier</surname>
   <given-names>P.</given-names>
  </name>; 
  <name>
   <surname>van der Hoek</surname>
   <given-names>L.</given-names>
  </name>
  <article-title>Inhibition of human coronavirus NL63 infection at early stages of the replication cycle</article-title>. 
  <source>Antimicrob. Agents Chemother.</source>
  <year>2006</year>, 
  <volume>50</volume>, 
  <fpage>2000</fpage>â€“
  <lpage>2008</lpage>. 
  <pub-id pub-id-type="doi">10.1128/AAC.01598-05</pub-id>.
  <pub-id pub-id-type="pmid">16723558</pub-id>
 </mixed-citation>
</ref>
